Parkwood LLC Vor Biopharma Inc. Transaction History

Parkwood LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.09 - $5.33 $161,254 - $278,151	52,186 Added 240.0%	73,930 $228,000
Q1 2023 May 15, 2023	BUY	$4.68 - $6.96 $101,761 - $151,338	21,744 New	21,744 $117,000
Q1 2022 May 13, 2022	SELL	$6.04 - $12.23 $237,806 - $481,519	-39,372 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$11.32 - $18.02 $112,781 - $179,533	-9,963 Reduced 20.19%	39,372 $458,000
Q3 2021 Nov 12, 2021	SELL	$12.24 - $20.38 $17,099 - $28,470	-1,397 Reduced 2.75%	49,335 $774,000
Q2 2021 Aug 13, 2021	BUY	$18.65 - $38.78 $946,151 - $1.97 Million	50,732 New	50,732 $946,000

41.1M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $53.3M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.